|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
11 September 2017 |
|
Main ID: |
ChiCTR-IPR-17012629 |
|
Date of registration:
|
2017-09-10 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Simplified regional citrate anticoagulation in continuous renal replacement therapy by using a calcium-containing replacement solution: a randomized controlled trial
|
|
Scientific title:
|
Simplified regional citrate anticoagulation in continuous renal replacement therapy by using a calcium-containing replacement solution: a randomized controlled trial |
|
Date of first enrolment:
|
2017-10-01 |
|
Target sample size:
|
Calcium-containing replacement solution:75;Calcium-free replacement solution:75; |
|
Recruitment status: |
Pending |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=17644 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Post-market
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
ZHANG LING
|
|
Address:
|
37 Guoxuexiang, Chengdu, Sichuan, China
610041
|
|
Telephone:
|
+86 18980601985 |
|
Email:
|
zhanglinglzy@163.com |
|
Affiliation:
|
Nephrology Department, West China Hospital, Sichuan University |
|
|
Name:
|
ZHANG LING
|
|
Address:
|
37 Guoxuexiang, Chengdu, Sichuan, China
610041
|
|
Telephone:
|
+86 18980601985 |
|
Email:
|
zhanglinglyz@163.com |
|
Affiliation:
|
Nephrology Department, West China Hospital, Sichuan University |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Patients who need renal replacement therapy, such as AKI, ESRD, acute drug or pesticide intoxication, etc.;
2. Haemodynamically stable;
3. Aged between 18 to 70 years old;
4. With written consent form patients.
Exclusion criteria: 1. Patients with citrate anticoagulant contraindications, such as Liver failure, irreversible hypotension, irreversible hypoxemia;
2. Organ transplant patients;
3. Pantients who can not cooperate because of mental illness or other reasons.
Age minimum:
18
Age maximum:
70
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Kidney diseases which are needed RCA-based CRRT therapy
|
|
Intervention(s)
|
|
Calcium-containing replacement solution:Calcium-containing replacement solution;Calcium-free replacement solution:Calcium-free replacement solution;
|
|
Primary Outcome(s)
|
|
Hemofilter survival;The percent of patent hemofilters;
|
|
Secondary Outcome(s)
|
|
creatinine;Blood urea nitrogen;Pre-filter and postfilter ionized calcium levels;Serum potassium;urine output;eGFR;
|
|
Source(s) of Monetary Support
|
|
Youth fund of Chinese Medical Association, No.13030330418
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|